| Literature DB >> 36008858 |
Kabir A Torres1, Elliot Konrade2, Jacob White3, Mauro Costa M Tavares Junior4, Joshua T Bunch4, Douglas Burton4, R Sean Jackson4, Jacob Birlingmair4, Brandon B Carlson5.
Abstract
BACKGROUND: The greater likelihood of morbidity, mortality, length of hospital stays and poorer long-term outcomes as a result of surgical site infections secondary to spinal surgery makes prophylactic measures an imperative focus. Therefore, the aim of this review was to evaluate the available research related to the efficacy of different intraoperative irrigation techniques used in spinal surgery for surgical site infection (SSI) prophylaxis.Entities:
Keywords: Complications; Infection prophylaxis; Irrigation techniques; Spinal surgery; Surgical irrigation; Surgical site infection
Mesh:
Substances:
Year: 2022 PMID: 36008858 PMCID: PMC9414142 DOI: 10.1186/s12891-022-05763-2
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.562
Fig. 1Flow diagram demonstrating article selection
Summary of all studies
| Reference | Year | N | Study Design | Patient Population | Primary Spine Diagnosis | Spine Location | Irrigation Technique | Volume of Irrigation Fluid | Total Infection Rate | Deep Infection Rate | Superficial Infection Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|
| De Luna et al. [ | 2017 | 50 | Prospective cohort | Adult | Scoliosis | Varied | Povidone-Iodine 0.3% | 2 L | 0% vs 12% (Post vs Pre) | N/A | N/A |
| Fei et al. [ | 2017 | 160 | Prospective cohort | Adult | Prolapsed lumbar intervertebral discs | Lumbar | Povidone-Iodine 0.1% | 200 mL | 0% vs 20% (Iodine vs Saline, Muscle layer) | N/A | N/A |
| Cheng et al. [ | 2005 | 417 | RCT | Adult | Varied | Varied | Povidone-Iodine 0.35% | 5 mL diluted | 0% vs 3.4% (Post vs. Pre) | 0% vs 2.9% (Post vs. Pre) | 0% vs 0.5% (Post vs. Pre) |
| Chang et al. [ | 2006 | 435 | RCT | Adult | Lumbosacral segmental instability | Lumbosacral | Povidone-Iodine 0.35% | N/A | 0% vs 4.8% | N/A | N/A |
| Sigari et al. [ | 2020 | 936 | RCT | Adult | Scoliosis or other degenerative disease | Varied | Povidone-Iodine 3.0% soaked for 2 min | N/A | 1.1% (Study) vs 4.5% (Control) | 0.42% (Study) vs 1.9% (Control) | 0.64% (Study) vs 2.6% (Control) |
| Savitz et al. [ | 1998 | 50 | Retrospective cohort | Adult | N/A | N/A | 50,000 units polymyxin and 50,000 units of bacitracin | 1L saline | N/A | N/A | N/A |
| Mastronardi [ | 2005 | 1167 | Retrospective cohort | Adult | Disc herniation | Lumbar | Rifamicin | N/A | 0.63% (Study) vs 0.66% (Control) | N/A | N/A |
| Watanabe et al. [ | 2010 | 223 | Retrospective cohort | Pediatric and Adult | Varied | Varied | Saline | N/A | 6,3% | N/A | N/A |
| Kaliaperumal [ | 2013 | 3063 | Retrospective cohort | Adult | Microdiscectomies | Lumbar | Savlon (chlorhexdine) | N/A | 0.18% (Saline) vs 0.09% (Savlon) | N/A | N/A |
| Tomov et al. [ | 2015 | 2425 | Retrospective cohort | Adult | Varied | Varied | Povidone-Iodine 0.3% | N/A | 1.3% vs 2.4% (Post vs Pre) | N/A | N/A |
| van Herwijnen [ | 2016 | 118 | Retrospective cohort | Pediatric | Scoliosis | Varied | 80 mg Gentamicin diluted in saline | 1L | 26.7% (Gentamicin) vs 7.0% (PVP-I) vs 6.2% (PVP-I + Vanc) | 20.0% (Gentamicin) vs 4.2%% (PVP-I) vs 3.1% (PVP-I + Vanc) | 6.7% (Gentamicin) vs 2.8% (PVP-I) vs 3.1% (PVP-I + Vanc) |
| Yamada et al. [ | 2018 | 1042 | Retrospective cohort | Adult | N/A | Varied | Povidone-Iodine 0.38% | 20 mL diluted in 500 mL saline | 0.7% vs 3.8% (Post vs Pre) | N/A | N/A |
| Karaarslan [ | 2018 | 166 | Retrospective cohort | Adult | Spinal stenosis and spondylolisthesis | Lumbar | 3 mL Rifampicin diluted with 5 mL saline | 8 mL | 1.2% (Rifampicin) vs 2.5% (Saline) | N/A | N/A |
| Lemans et al. [ | 2019 | 853 | Retrospective cohort | Adult | N/A | Varied | Povidone-Iodine 0.013% | 500 mL at 1.3 g/L | N/A | 9.7% vs 9.7% (Post vs. Pre) | 0.9% vs 5.1% (Post vs. Pre) |
| Onishi et al. [ | 2019 | 323 | Retrospective cohort | Adult | N/A | Varied | Povidone-Iodine 1.0% pooled every 1.5 h | N/A | 1.7% (Study) vs 3.4% (Control) | 0.0% (Study) vs 2.7% (Control) | 1.7% (Study) vs 0.7% (Control) |
| Tipper et al. [ | 2020 | 414 | Retrospective cohort | Pediatric | Scoliosis | Varied | Saline | N/A | 2,2% | N/A | N/A |
| Chen et al. [ | 2020 | 2626 | Retrospective cohort | Adult | Spinal canal stenosis, disc herniation, spondylolisthesis, and/or degenerative scoliosis; | Thoracic/Lumbar | 3% Hydrogen Peroxide | 50 mL | 1.4% (Hydrogen Peroxide) vs 2.4% (Saline) | 0.2% (Hydrogen Peroxide) vs 1.1% (Saline) | 1.2% (Hydrogen Peroxide) vs 1.3% (Saline) |
| Carballo Cuello et al. [ | 2021 | 278 | Retrospective cohort | Adult | N/A | Lumbar | Povidone-Iodine 0.35% | 35 ml of sterile 10% PVP-I in 1L of 0.9% saline | 6.7% (saline) vs 0.7% (PVP-I | N/A | N/A |
N Number, N/A Not applicable, RCT Randomized clinical trial
Fig. 2Comparison between intraoperative wound irrigation with povidone-iodine versus controls in their association with SSIs. Legends: CI, confidence interval; M-H, Mantel–Haenszel; PVPI, povidone-iodine
Fig. 3Funnel plot of the association between estimated effect size of each povidone-iodine study and standard error. Legends: RR, risk ratio; SE, standard error
Fig. 4Comparison between povidone-iodine (only RCT and prospective cohort studies) versus controls in their association with SSIs. Legends: PVPI, povidone-iodine; RCT, randomized clinical trials; CI, confidence interval; M-H, Mantel–Haenszel
PROBAST Results
| Study | ROB | Applicability | Overall | ||||||
|---|---|---|---|---|---|---|---|---|---|
| + | + | ? | + | + | + | + | ? | + | |
| + | + | ? | + | + | + | ? | ? | ? | |
| + | + | ? | + | + | + | + | ? | + | |
| + | + | ? | + | + | + | ? | ? | ? | |
| + | + | + | + | + | + | ? | + | ? | |
| + | + | + | + | + | + | ? | + | ? | |
| ? | + | + | + | + | + | ? | ? | ? | |
| + | ? | ? | + | + | ? | ? | - | ? | |
| + | + | + | + | + | + | ? | + | ? | |
| ? | + | + | + | + | + | + | ? | + | |
| + | + | + | + | + | + | + | + | + | |
| + | + | ? | + | + | ? | ? | ? | - | |
| + | ? | - | + | + | + | - | - | - | |
| + | ? | + | + | + | + | + | ? | + | |
| - | + | + | + | + | + | ? | - | ? | |
| + | + | + | + | + | + | ? | + | ? | |
| + | + | ? | + | + | + | ? | ? | ? | |
| + | ? | ? | + | + | + | + | ? | + | |
PROBAST Prediction model Risk Of Bias Assessment tool, ROB Risk of bias
+ indicates low ROB/low concern regarding applicability;
- indicates high ROB/high concern regarding applicability;
? indicates unclear ROB/unclear concern regarding applicability